Skip to main content
Stephen Spector, MD, Pediatric Infectious Disease, San Diego, CA

StephenAllenSpectorMD

Pediatric Infectious Disease San Diego, CA

Pediatric Infections Associated with Transplant/Immunocompromised States, Pediatric Vaccinology and Vaccine Preventable Diseases, Perinatal Infections

Professor, Pediatrics, UCSD School of Medicine

Dr. Spector is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Spector's full profile

Already have an account?

  • Office

    330 Lewis St
    San Diego, CA 92103
    Phone+1 800-926-8273
    Fax+1 619-298-2698

Education & Training

  • University of California (San Diego) Medical Center
    University of California (San Diego) Medical CenterFellowship, Infectious Disease, 1978 - 1981
  • University of California (San Francisco)
    University of California (San Francisco)Residency, Pediatrics, 1975 - 1978
  • Tufts University School of Medicine
    Tufts University School of MedicineClass of 1975

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1976 - 2025
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Infectious Diseases

Awards, Honors, & Recognition

  • Honored The Gertrude and Herman Silver Award from the Children’s, 2010
  • Fellow (FAAP) American Academy of Pediatrics

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine  
    Karen Kotloff, Stephen A Spector, Carlos Fierro, The New England Journal of Medicine
  • Human Immunodeficiency Virus Type-1 gp120 and Tat Induce Mitochondrial Fragmentation and Incomplete Mitophagy in Human Neurons  
    Stephen Spector, MD, mBio

Press Mentions

  • New Reassessments of How Clinical Trials Can and Should Be Conducted
    New Reassessments of How Clinical Trials Can and Should Be ConductedFebruary 3rd, 2023
  • San Diego Toddler Enrolled in Pfizer COVID Vaccine Trial
    San Diego Toddler Enrolled in Pfizer COVID Vaccine TrialNovember 23rd, 2021
  • Pfizer Seeks Emergency Use Authorization from FDA for Vaccine in Children 5 to 11 Years Old
    Pfizer Seeks Emergency Use Authorization from FDA for Vaccine in Children 5 to 11 Years OldSeptember 21st, 2021
  • Join now to see all

Grant Support

  • Host Genetic Factors Associated With CNS Disease Of Hiv-Infected ChildrenNational Institute Of Neurological Disorders And Stroke2011–2012
  • University Of California, SAN Diego Clinical Trial UnitNational Institute Of Allergy And Infectious Diseases2007–2012
  • Clinical Trial: Impaact 1071National Center For Research Resources2010
  • Clinical Trial: Antiretroviral Activity Of Raltegravir In HIV-1 Infected ChildreNational Center For Research Resources2010
  • Vitamin D Inhibition Of HIV And M. Tuberculosis Coinfection In MacrophagesNational Institute Of Allergy And Infectious Diseases2009–2010
  • Healthy Subject Cell CollectionNational Center For Research Resources2009–2010
  • Adolescent Master Protocol (AMP) - Impact Of HIV And ART On GrowthNational Center For Research Resources2008–2010
  • Clinical Trial: Pactg P1025 Pharmacokinetic Properties Of Antiretroviral DrugsNational Center For Research Resources2009
  • CCTG 560a: Viral Population KineticsNational Center For Research Resources2009
  • Clinical Trial: Pactg 1020a Novel Protease Inhibitor Bms-232632 In Children WithNational Center For Research Resources2008–2009
  • Clinical Trial: Pactg P1025 Pharmacokinetic Properties Of Antiretroviral Drugs DNational Center For Research Resources2008
  • Healthy Donor CellsNational Center For Research Resources2006–2008
  • VirologyNational Institute Of Allergy And Infectious Diseases2007
  • Pactg P1021 Emtricitabine And Efavirenz And Didanosine In HIVNational Center For Research Resources2007
  • Pactg P1025 Pharmacokinetic Properties Of Antiretroviral Drugs During PregnancyNational Center For Research Resources2005–2007
  • Pactg 1020a Novel Protease Inhibitor Bms-232632 In Children With HIVNational Center For Research Resources2005–2007
  • Pactg P1039 Zidovudine/Lamivudine/Abacavir In Perinatal HIVNational Center For Research Resources2006
  • Pediatric AIDS Clinical Trials GroupNational Institute Of Allergy And Infectious Diseases1988–2006
  • Pactg P1052 Abacavir PK During Chronic Therapy In HIV InfectionNational Center For Research Resources2005
  • Pactg P1022 Protease Inhibitor-Including/Sparing For HIV During PregnancyNational Center For Research Resources2005
  • Normal Donor Cells For HIV AssaysNational Center For Research Resources2005
  • ACTG 382 DMP 266 In Combination Wit Nelfinavir In Children With HIVNational Center For Research Resources2005
  • Pediatric ACTG Coordinating And Operations CenterNational Institute Of Allergy And Infectious Diseases2002–2005
  • Adolescent Medicine Trials Unit (AMTU)Eunice Kennedy Shriver National Institute Of Child Health &Human Development2002–2005
  • Factors In Pediatric AIDS Transmission And PathogenesisNational Institute Of Allergy And Infectious Diseases2001–2005
  • Protease Inhibitor Including Sparing For HIV PregnancyNational Center For Research Resources2004
  • Pharmacokinetics Of Antiretrovirals During PregnancyNational Center For Research Resources2004
  • Pactg P1021 Emtricitabine/Efavirenz/Didanosine In HIVNational Center For Research Resources2004
  • Normal Donor CellsNational Center For Research Resources2004
  • Actg382--Dmp 266 In Combination W/Nelfinavir In ChildrenNational Center For Research Resources2004
  • Core -- Adolescent Medical TrialsNational Center On Minority Health And Health Disparities2002
  • Ritonavir Therapy In HIV-1 Infected Infants And ChildrenNational Center For Research Resources2000–2002
  • Comparison Of Combinations Of PI, Nrti, And NnrtiNational Center For Research Resources2000–2002
  • ZDV &3tc &Nevirapine &Zdv &3tc &Nevirapine &1592u89 In HIV InfectionNational Center For Research Resources1999–2002
  • Evaluation Of Ganciclovir For Congenital CytomegalovirusNational Center For Research Resources1999–2002
  • Actg382--I592089 With Standard Zidovudine Therapy In NeonatesNational Center For Research Resources1999–2002
  • Adolescent Medicine Trial Network For HIV/AIDSEunice Kennedy Shriver National Institute Of Child Health &Human Development2001
  • Pediatric AIDS Clinical Trials Group--Coordinate/OperateNational Institute Of Allergy And Infectious Diseases1999–2001
  • Core--Clinical Virology And Specimen BankingNational Institute Of Allergy And Infectious Diseases1998–2001
  • ACTG 395 Indinavir W/ Stavudine &Lamivudine In Pediatric HIVNational Center For Research Resources1999
  • ACTG 358--Oral Indinavir In HIV Pregnant Women &InfantsNational Center For Research Resources1999
  • Actg330--1592u89 In Infants And Children With HIV InfectionNational Center For Research Resources1998–1999
  • ACTG 250 Nevirapine In HIV-1 Pregnant Women And NeonatesNational Center For Research Resources1997–1999
  • Hivig For The Prevention Of Maternal-Fetal HIV TransmissionNational Center For Research Resources1996–1999
  • ACTG 300 Zidovudine VS DDI Monotherapy VS Didovudine PLUS DDI In HIV InfectionNational Center For Research Resources1996–1999
  • ACTG 226 Oral Ganciclovir In HIV Infected Children With Cytomegalovirus InfectionNational Center For Research Resources1996–1999
  • Pediatric Aids--Factors In Transmission And PathologyNational Institute Of Allergy And Infectious Diseases1995–1999
  • Actg383--Dmp 266 In Combination With Nelfinavir In ChildrenNational Center For Research Resources1998
  • Pediatric AIDS Clinical Trials Group--Coordinate/OperateNational Institute Of Allergy And Infectious Diseases1997–1998
  • Actg179 Evaluation Of Ganciclovir For Congenital CytomegalovirusNational Center For Research Resources1997–1998
  • Ctg254 Azithromycin &M-Atovaquone &Azithromycin-Bacterial Infection?D?D?D?D?D?National Center For Research Resources1997
  • Actg152 Trial Of AZT VS DDI VS Azt/Ddi In HIV Infected ChildrenNational Center For Research Resources1997
  • Salvage DDC For Symptomatic HIV Infected Children Failing DDI TherapyNational Center For Research Resources1996–1997
  • Core--Primary Isolation And Specimen BankingNational Institute Of Allergy And Infectious Diseases1994–1997
  • Actg240 Trial Of ZDV VS D4T In Children With HIV InfectionNational Center For Research Resources1996
  • ACTG 245 Antiretroviral Therapy In Children With Advanced HIVNational Center For Research Resources1996
  • Pediatric AIDS Clinical ResearchNational Institute Of Allergy And Infectious Diseases1994–1996
  • Developmental Virology ResearchNational Institute Of Allergy And Infectious Diseases1994–1996
  • Core--Virology LAB SupportNational Institute Of Allergy And Infectious Diseases1994–1996
  • AIDS Clinical TrialsNational Institute Of Allergy And Infectious Diseases1994–1995
  • Molecular Interaction Of HIV HCMVNational Institute Of Allergy And Infectious Diseases1989–1995
  • Adult AIDS Clinical Trials UnitNational Institute Of Allergy And Infectious Diseases1992–1993
  • AIDS Clinical Trials GroupNational Institute Of Allergy And Infectious Diseases1989–1991
  • AIDS Clinical Trials Group (Conversion From Ateu)National Institute Of Allergy And Infectious Diseases1988

Professional Memberships